Related Experiment Videos

[Expression and antagonist role of endothelin and nitric oxide synthase in atherosclerotic plaque]

L Song1, D Wang, T Wang

  • 1Institute of Cardiovascular Basic Research, Beijing Medical University.

Abstract

Insights

Atherosclerotic plaque formation is linked to an imbalance between endothelin (ET) and nitric oxide synthase (NOS). Increased ET and decreased NOS expression contribute to this condition.

Area of Science:

  • Cardiovascular Biology
  • Molecular Pathology

Context:

  • Atherosclerosis is a complex disease involving plaque buildup in arteries.
  • Endothelin (ET) and nitric oxide synthase (NOS) play critical roles in vascular function and homeostasis.

Purpose:

  • To investigate the pathogenetic mechanism of atherosclerotic plaque.
  • To study the interplay between endothelin (ET) and nitric oxide synthase (NOS) in atherosclerosis.

Summary:

  • Studies show increased endothelin mRNA and decreased nitric oxide synthase mRNA in atherosclerotic plaques.
  • Endothelin inhibits nitric oxide synthase protein synthesis in vascular smooth muscle cells (VSMC).
  • ET receptor antagonists can block endothelin's inhibitory effect on NOS protein.

Impact:

  • Findings suggest that an imbalance favoring ET over NOS contributes to atherosclerotic plaque formation.
  • This research highlights potential therapeutic targets for managing atherosclerosis by modulating ET and NOS pathways.

Related Concept Videos